Blog
RSS FeedPosted by Michael Wonder on 22 Jan 2019
Access, value and investment: making the right choices for a healthy Australia
22 January 2019 - Medicines Australia has today lodged its submission to the 2019-2020 Federal Budget. ...
Posted by Michael Wonder on 22 Jan 2019
PTAC recommends Keytruda for patients with non-small cell lung cancer
22 January 2019 - PTAC reviewed an application from Merck Sharpe and Dohme for the funding of pembrolizumab in combination ...
Posted by Michael Wonder on 21 Jan 2019
NHS England sees off AbbVie's hepatitis C legal challenge
21 January 2019 - Claims of unfair process dismissed by High Court. ...
Posted by Michael Wonder on 21 Jan 2019
New agreement on branded drugs for the NHS
18 January 2019 - The new Voluntary Scheme for Branded Medicines Pricing and Access began on 1 January and was ...
Posted by Michael Wonder on 21 Jan 2019
Canadian payer reports a successful switch to biosimilars
21 January 2019 - In 2018, Green Shield Canada launched its pilot Biosimilar Transition Program, through 3 plan sponsors, under which ...
Posted by Michael Wonder on 21 Jan 2019
Millennials turn to Afterpay to cover dental costs
22 January 2019 - Millennials are turning to buy-now-pay-later juggernaut Afterpay to cover dental costs as they shun private health ...
Posted by Michael Wonder on 21 Jan 2019
Confusion abounds around health insurance reforms
21 January 2019 - For reforms that are meant to simplify private health cover, some are still a confusing maze. ...
Posted by Michael Wonder on 21 Jan 2019
Contraceptive pill Levlen ED rationed as supply runs low across New Zealand
21 January 2019 - Popular contraceptive pill Levlen ED is being rationed amidst fears of a shortage. ...
Posted by Michael Wonder on 21 Jan 2019
Will price be a barrier to new cancer immunotherapy?
19 January 2019 - Advisory group CADTH recommends no funding for new CAR-T therapy until drug company lowers cost. ...
Posted by Michael Wonder on 20 Jan 2019
Tauranga women fighting cancer, and fighting the system
19 January 2019 - Two Tauranga woman, each living with a terminal diagnosis, are calling for an independent inquiry into ...
Posted by Michael Wonder on 20 Jan 2019
How much is preventing a heart attack worth?
20 January 2019 - A newly developed family of drugs could cut cholesterol by up to 75% and prevent thousands ...
Posted by Michael Wonder on 20 Jan 2019
Expensive lung cancer drug added to PBS
20 January 2019 - A drug that helps patients suffering lung cancer has been added to the Pharmaceutical Benefits Scheme. ...
Posted by Michael Wonder on 18 Jan 2019
NICE OK for Bravtovi skin cancer drug
18 January 2019 - NICE has recommended Pierre Fabre’s Bravtovi (encorafenib) and Mektovi (binimetinib) combination as an option for some ...
Posted by Michael Wonder on 18 Jan 2019
Canada’s drug pricing regulator brings rare allegation of excessive pricing against Horizon Pharma
17 January 2019 - Canada’s drug-pricing regulator is accusing an Irish pharmaceutical company of charging an excessive price for a ...
Posted by Michael Wonder on 18 Jan 2019
Patient groups fail to declare financial interests during NICE assessments
16 January 2019 - Patients’ groups involved in assessing treatments for the NHS often fail to disclose their financial interests, ...